Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Cashmere Karen A. Director |
572 | $0 | 572 (Direct) |
View |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer |
715 | $0 | 715 (Direct) |
View |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer |
1,627 | $0 | 1,627 (Direct) |
View |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Park Min-Chul Director |
132 | $0 | 132 (Direct) |
View |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Freitag Gregory Gene Director |
132 | $0 | 132 (Direct) |
View |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | SAPIRSTEIN JAMES Director |
132 | $0 | 132 (Direct) |
View |
2023-05-24 Option Award |
2024-07-18 9:35 pm |
N/A 2033-05-24 |
ZyVersa Therapeutics Inc. | ZVSA | Finizio Robert G Director |
132 | $0 | 132 (Direct) |
View |
2023-01-26 Option Award |
2023-01-26 8:25 pm |
N/A 2033-01-26 |
ZyVersa Therapeutics Inc. | ZVSA | Guzman Pablo A. Chief Medical Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2023-01-26 8:22 pm |
N/A N/A |
ZyVersa Therapeutics Inc. | ZVSA | Guzman Pablo A. Chief Medical Officer |
0 | $0 | 107,934 (Direct) |
View |
2022-12-16 Option Award |
2022-12-20 4:00 pm |
N/A N/A |
ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer |
3,000 | $2.8815 | 44,585 (Direct) |
View |
2022-12-12 Option Award |
2022-12-16 9:41 pm |
N/A 2027-12-12 |
ZyVersa Therapeutics Inc. | ZVSA | INCON Co. Ltd. 10% Owner |
1,947,901 | $0 | 1,947,901 (Direct) |
View |
2022-12-12 Option Award |
2022-12-14 7:40 pm |
N/A 2029-04-02 |
ZyVersa Therapeutics Inc. | ZVSA | Finizio Robert G Director |
59,562 | $0 | 59,562 (Direct) |
View |
2022-12-12 Option Award |
2022-12-14 7:37 pm |
N/A 2025-10-21 |
ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer |
174,648 | $0 | 174,648 (Direct) |
View |
2022-12-12 Option Award |
2022-12-14 7:34 pm |
N/A 2031-07-01 |
ZyVersa Therapeutics Inc. | ZVSA | Park Min-Chul Director |
39,708 | $0 | 39,708 (Direct) |
View |
2022-12-12 Option Award |
2022-12-14 7:31 pm |
N/A 2024-04-11 |
ZyVersa Therapeutics Inc. | ZVSA | LaBella Nicholas A. Jr. Chief Scientific Officer |
236,490 | $0 | 254,584 (Direct) |
View |
2022-12-12 Option Award |
2022-12-14 7:27 pm |
N/A 2024-09-10 |
ZyVersa Therapeutics Inc. | ZVSA | Cashmere Karen A. Chief Commercial Officer |
103,242 | $0 | 103,242 (Direct) |
View |
2022-12-12 Option Award |
2022-12-14 7:24 pm |
2022-12-12 N/A |
ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer |
1,499,542 | $0 | 1,366,196 (Direct) |
View |
2022-12-12 Other |
2022-12-14 7:21 pm |
2022-12-12 N/A |
ZyVersa Therapeutics Inc. | ZVSA | O'Connor Daniel J. Larkspur Health LLC Director 10% Owner |
1,558,302 | $0 | 2,935,900 (Direct) |
View |
2022-01-06 Other |
2022-03-10 5:32 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Larkspur Health LLC 10% Owner |
239,700 | $0 | 1,613,872 (Direct) |
View |
2022-01-06 Other |
2022-03-10 5:32 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Mehra Raj Director |
953 | $0 | 8,631 (Direct) |
View |
2022-01-06 Other |
2022-03-10 5:31 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | O'Connor Daniel J. Chief Executive Officer |
66,018 | $0 | 487,097 (Indirect) |
View |
2022-01-06 Other |
2022-03-10 5:30 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Twitty Christopher Director |
953 | $0 | 8,631 (Direct) |
View |
2022-01-06 Other |
2022-03-10 5:30 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Skalicky Gregory Director |
953 | $0 | 8,631 (Direct) |
View |
2022-01-06 Other |
2022-03-10 5:30 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Briones David S. Chief Financial Officer |
12,376 | $0 | 133,594 (Indirect) |
View |
Ownership |
2022-03-10 5:29 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Larkspur Health LLC 10% Owner |
0 | $0 | 1,374,172 (Direct) |
View |
2022-03-08 Other |
2022-03-08 1:51 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. 10% Owner |
3,427 | $0 | 450,270 (Direct) |
View |
2022-02-03 Other |
2022-02-07 7:36 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | A.G.P. / ALLIANCE GLOBAL PARTNERS CORP. 10% Owner |
49,730 | $0 | 500,000 (Direct) |
View |
Ownership |
2021-12-20 6:26 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Skalicky Gregory Director |
0 | $0 | 9,584 (Direct) |
View |
Ownership |
2021-12-20 6:25 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Mehra Raj Director |
0 | $0 | 9,584 (Direct) |
View |
Ownership |
2021-12-20 6:24 pm |
N/A N/A |
Larkspur Health Acquisition Corp. | LSPR | Briones David S. Chief Financial Officer |
0 | $0 | 57,500 (Direct) |
View |